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Introduction: Although chronic obstructive pulmonary disease (COPD) has been implicated as a risk factor for abdominal
aortic aneurysm (AAA) rupture, its effect on surgical repair is less deﬁned. Consequently, variation in practice persists
regarding patient selection and surgical management. The purpose of this study was to analyze the effect of COPD on
patients undergoing AAA repair.
Methods: We reviewed a prospective regional registry of 3455 patients undergoing elective open AAA repair (OAR) and
endovascular AAA repair (EVAR) from 23 centers in the Vascular Study Group of New England from 2003 to 2011.
COPD was categorized as none, medical (medically treated but not oxygen [O2]-dependent), and O2-dependent. End
points included in-hospital death, pulmonary complications, major postoperative adverse events (MAEs), extubation in
the operating room, and 5-year survival. Survival was determined using life-table analysis based on the Social Security
Death Index. Predictors of in-hospital and long-term mortality were determined by multivariate logistic regression and
Cox proportional hazards analysis.
Results: During the study interval, 2043 patients underwent EVAR and 1412 patients underwent OAR with a nearly
equal prevalence of COPD (35% EVAR vs 36% OAR). O2-dependent COPD (4%) was associated with signiﬁcantly
increased in-hospital mortality, pulmonary complications, and MAE and was also associated with signiﬁcantly decreased
extubation in the operating room among patients undergoing both EVAR and OAR. Five-year survival was signiﬁcantly
diminished among all patients undergoing AAA repair with COPD (none, 78%; medical, 72%; O2-dependent, 42%;
P < .001). By multivariate analysis, O2-dependent COPD was independently associated with in-hospital mortality (odds
ratio 2.02, 95% conﬁdence interval, 1.0-4.0; P[ .04) and diminished 5-year survival (hazard ratio, 3.02; 95% conﬁdence
interval, 2.2-4.1; P < .001).
Conclusions: Patients with O2-dependent COPD undergoing AAA repair suffer increased pulmonary complications,
overall MAE, and diminished long-term survival. This must be carefully factored into the risk-beneﬁt analysis before
recommending elective AAA repair in these patients. (J Vasc Surg 2013;57:1531-6.)The clinical management of patients with severe
chronic obstructive pulmonary disease (COPD) in the
setting of abdominal aortic aneurysms (AAA) remains an
ongoing challenge in contemporary practice. Oxygen
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://dx.doi.org/10.1016/j.jvs.2012.11.132older studies to be associated with poor clinical outcomes
after open AAA repair (OAR) and is also an independent
predictor of AAA rupture.1-3 Accordingly, patient selection
for elective AAA repair in patients with COPD is more difﬁ-
cult, and variation in practice persists in patient selection and
surgical management. Moreover, clinical decision making in
treatment of patients with COPD and AAA is perhaps
further complicated by the application and evolution of
endovascular AAA repair (EVAR), which has affected the
perioperative morbidity proﬁle in treating AAA.4-8
Despite a substantial body of literature devoted to
COPD, there is a relative paucity of surgical literature
about the effect of clinically signiﬁcant COPD on AAA
repair in the modern, endovascular era. In addition,
comparisons with historical control groups of AAA cohorts
often reﬂect AAA patients who were treated before the
widespread adoption of statin therapy, which may improve
survival and affect the natural history of AAA. This study
used a prospective regional registry to analyze the effect
of COPD on patients undergoing AAA repair in contem-
porary real-world practice.1531
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Patients and database. This study reﬂects data
collected in the prospectively compiled regional registry
of the Vascular Study Group of New England (VSGNE).9
The use of deidentiﬁed data for this analysis was approved
by the Committee for the Protection of Human Subjects of
Dartmouth Medical School. All patients undergoing elec-
tive OAR and EVAR repair from 23 centers in New
England from 2003 to 2011 were reviewed (n ¼ 3455).
The analysis excluded ruptured and symptomatic AAA and
juxtarenal and suprarenal aneurysms. There was a small
difference in mean maximal AAA diameter among those
undergoing EVAR vs OAR (57 vs 60 mm). Selection of
EVAR or OAR was at the discretion of the operating
surgeon.
Outcomes and variable deﬁnitions. COPD was cate-
gorized as none, medical (medically treated but not O2-
dependent), and O2-dependent. The end points of this
study included in-hospital death, pulmonary complica-
tions (pneumonia/ventilatory failure), major postoperative
adverse events (MAEs), extubation in the operating room,
and 5-year survival, which was determined by matching
patients in the VSGNE database with the Social Security
Death Index. MAEs included in-hospital death, post-
operative myocardial infarction, new-onset congestive
heart failure or cardiac dysrhythmia, respiratory failure,
decline in renal function (by at least 20%), lower extremity
ischemia, mesenteric ischemia, or unplanned reoperation.
Chronic renal insufﬁciency was deﬁned as a creatinine value
of $1.8 mg/dL. Ventilatory failure reﬂected a composite
of pulmonary complications, including reintubation and
prolonged ventilator support.
Statistical analysis. Data were compared using
c2 analysis for dichotomous and categoric variables and
the t-test or analysis of variance (ANOVA) for continuous
variables. Comparisons were made across all groups,
comparing O2-dependent patients with those with no
COPD and those with medically managed disease. Survival
was determined using life-table analysis. Variables associ-
ated with end points were initially identiﬁed by univariate
analysis using c2 test, with the Fisher exact test substituted
where needed.
Variables signiﬁcant at P < .10 were entered into
a multivariable model using backwards stepwise logistic
regression. Predictors of in-hospital and long-term mor-
tality were determined by multivariate logistic regression
(in-hospital mortality) and Cox proportional hazards anal-
ysis (5-year survival). Hazard ratios (HR), odds ratios
(OR), and 95% conﬁdence intervals (CIs) were generated
for signiﬁcant end point predictors.
RESULTS
During the study interval, 3455 patients underwent
elective AAA repair. Among them, 2043 patients underwent
EVAR and 1412 underwent OAR with near equal preva-
lence of COPD (35% EVAR vs 36% OAR). Of the study
cohort, 2238 patients (65%) had no COPD, 1082 (31%)had medically managed COPD, and 135 (4%) had O2-
dependent COPD. Demographic details and comorbidities
of patients stratiﬁed by COPD severity are summarized in
Table I.
In-hospital mortality was signiﬁcantly increased among
patients with any COPD undergoing AAA repair (none,
1%; medically managed, 2.1%, O2-dependent, 2.0%;
P ¼ .02). Further analysis of this cohort when stratiﬁed
by repair type revealed that in-hospital death did not
differ among patients undergoing EVAR. By comparison,
in-hospital death was signiﬁcantly higher among O2-
dependent patients undergoing OAR. For each category
of COPD severity, in-hospital mortality was signiﬁcantly
higher among those undergoing OAR (Fig 1).
Postoperative pulmonary complications were signiﬁ-
cantly higher among all O2-dependent patients undergoing
AAA repair (none, 4.3%; medically managed, 8.7%; O2-
dependent, 10.4%; P < .001). When analyzed by operation
type (EVAR vs OAR), O2-dependent patients experienced
signiﬁcantly higher rates of pulmonary complications after
EVAR and OAR. For each category of COPD severity,
pulmonary complications were signiﬁcantly higher among
those undergoing OAR (Fig 2).
MAEs were also signiﬁcantly higher among patients
with O2-dependent COPD than in patients without
COPD (none, 14.9%; medically managed, 21%; O2-depen-
dent, 22.6%; P < .001). When assessed by speciﬁc repair
type, the number of patients experiencing MAEs was
signiﬁcantly increased among those with O2 dependence
for EVAR and OAR. In addition, for each category of
COPD severity, MAEs were signiﬁcantly higher among
those undergoing OAR (Fig 3).
The incidence of successful extubation in the operating
room was substantially diminished among those with O2-
dependent COPD than in noneO2-dependent patients
(none, 87.3%; medically managed, 81.5%; O2-dependent,
79.4%; P < .001). Patients with O2 dependence also expe-
rienced lower rates of extubation in the operating room,
irrespective of repair type. Similar to other end points,
extubation in the OR was signiﬁcantly decreased among
patients for each category of COPD severity undergoing
OAR (Fig 4). The 280 patients who underwent EVAR
under regional anesthesia were excluded from this speciﬁc
subanalysis.
Survival at 5 years was signiﬁcantly decreased among
patients with O2-dependent COPD undergoing AAA
repair compared with those with no COPD or medically
managed disease (none, 79%; medical, 72%; O2-dependent,
42%; P < .001; Fig 5). In addition, when 5-year survival
was stratiﬁed by procedure type, a small but statistically
signiﬁcant difference was found between OAR (78%) and
EVAR patients (72%) at 5 years (P ¼ .047).
Multivariate logistic regression conﬁrmed that O2-
dependent COPD was an independent predictor of in-
hospital death (OR, 2.0; P¼ .04). In addition, age>80 years
(OR, 3.8; P ¼ .004), coronary artery disease (OR, 1.8;
P ¼ .05), and OAR (OR, 5.1; P < .001) were also indepen-
dent predictors of in-hospital death. Cox proportional
Fig 1. Rates of in-hospital death are shown stratiﬁed by chronic
obstructive pulmonary disease (COPD) severity and endovascular
(EVAR) or open abdominal aortic aneurysm repair.
Table I. Patient demographics and comorbidities for
total study cohort stratiﬁed by COPD severity
Variablea
COPD
Pb
None
(n ¼ 2238)
Medical
(n ¼ 1082)
O2 dependent
(n ¼ 135)
Age, years 72 6 8.9 72 6 7.9 75 6 7.3 .005
Female sex 19 (425) 26 (281) 36 (49) .001
Coronary artery
disease
31 (694) 39 (422) 38 (51) .001
Congestive heart
failure
6 (134) 12 (130) 24 (32) .001
Smoking 85 (1902) 97 (1050) 93 (126) .001
Diabetes mellitus 17 (380) 29 (206) 19 (26) .38
Hypertension 84 (1880) 84 (909) 87 (117) .49
CRI (Cr >
1.8 mg/dL)
7 (157) 6 (65) 6 (8) .72
Aspirin 72 (1613) 72 (779) 65 (88) .21
Statin 69 (1545) 66 (715) 64 (87) .15
b-blocker 80 (1786) 82 (885) 64 (87) .0001
COPD, Chronic obstructive pulmonary disease; Cr, creatinine; CRI, chronic
renal insufﬁciency; SD, standard deviation.
aCategoric data are shown as number (%) and continuous data as mean 6
standard deviation.
bP values reﬂect a c2 analysis across all three cohorts.
Fig 2. Rates of pulmonary complications are shown stratiﬁed by
chronic obstructive pulmonary disease (COPD) severity and
endovascular (EVAR) or open abdominal aortic aneurysm repair.
Pulmonary complications were deﬁned as pneumonia or respiratory
failure.
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also independently associated with decreased 5-year sur-
vival (HR, 3.0; P < .001). Other independent predictors
of diminished 5-year survival were age >80 years (HR,
2.69; P < .001), chronic renal insufﬁciency (HR, 1.91;
P < .001), coronary artery disease (HR, 1.46; P < .001),
congestive heart failure (HR, 1.46; P¼ .002), and medically
managed COPD (HR, 1.22; P ¼ .02). Aspirin (HR, 0.78;
P ¼ .005) and statin therapy (HR, 0.79, P ¼ .007) were
independently associated with improved 5-year survival
(Table II).DISCUSSION
This study, using a prospective regional registry, is
among the ﬁrst to better deﬁne real-world outcomes of
patients with O2-dependent COPD undergoing AAA
repair in the endovascular era. Multiple studies have inves-
tigated the effect of clinically signiﬁcant COPD on rupture
risk, operative outcomes, and long-term survival; however,
many remain single-center retrospective studies with statis-
tically modest sample sizes and thus are more ﬁnite in their
conclusions guiding clinical decision making.1,10-12 In
addition, many of these studies antedate the evolution
and widespread application of EVAR, which has altered
the morbidity and mortality proﬁle of AAA repair.4-7
Patient selection for operative AAA repair remains
predicated on a careful assessment of current risks and
beneﬁts. Driving this decision is the longitudinal risk of
rupture vs the risks of elective perioperative morbidity
and mortality as well as long-term survival. Some studies
have demonstrated increased operative mortality and
morbidity in patients with COPD, but others have docu-
mented no differences in associated death.8,10,11,13-16
Axelrod et al,11 using the Veterans Affairs Department
Patient Treatment File for 1997 to 1998, found no associ-
ated difference in mortality after elective repair among
patients with COPD vs those without (3.7% vs 3.7%, P ¼
.99). However, this study did demonstrate an increased
risk of prolonged ventilation, increased length of stay,
and increased intensive care unit length of stay in the
COPD cohort.11 Unfortunately, this study did not distin-
guish EVAR vs OAR. Moreover, the Veterans Affairs data-
base used in this analysis was unable to stratify patients by
COPD severity. Thus, results pertaining to mortality may
have reﬂected the inevitable inclusion of patients with
Fig 3. Rates of major adverse events are shown stratiﬁed by
chronic obstructive pulmonary disease (COPD) severity and
endovascular (EVAR) or open abdominal aortic aneurysm repair.
Major adverse events reﬂected a composite of in-hospital death,
postoperative myocardial infarction, new-onset congestive heart
failure or cardiac dysrhythmia, respiratory failure, decline in renal
function (by at least 20%), lower extremity ischemia, mesenteric
ischemia, or unplanned reoperation.
Fig 4. Rates of extubation in the operating room are shown
stratiﬁed by chronic obstructive pulmonary disease (COPD)
severity and endovascular (EVAR) or open abdominal aortic
aneurysm repair.
Fig 5. Kaplan-Meier life table analysis shows 5-year survival
stratiﬁed by severity of chronic obstructive pulmonary disease. All
standard error was <10%.
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limiting the study’s ability to stratify outcomes across
disease severity.
Upchurch et al,12 in a single-center review of 158 patients
treated with OAR, similarly concluded that COPD alone
should not be considered a deterrent in offering surgical
treatment. Although the authors were able to providespirometric and arterial blood gas information, their
analytic cohort reﬂected only 8% O2-dependent patients
in the uncomplicated outcome group and 12% in the
complicated outcome group. This amounted to 13 patients
on home O2 available for analysis; thus, results might have
been driven predominantly by those with less severe
pulmonary compromise.12 Furthermore, their study re-
ﬂected only those patients undergoing OAR but not
EVAR. Accordingly, debate persists about patient selection
for AAA repair, especially among O2-dependent patients.
More recently, Compton et al1 reported 44 patients
with O2-dependent COPD undergoing EVAR (n ¼ 24)
and OAR (n ¼ 20) during an 8-year period. They reported
0% operative mortality and suggested that overall survival
in this group compared favorably with historical estimates
of the survival of untreated patients with 6-cm AAA. As
in previous reports, length of stay was extended in O2-
dependent patients compared with standard-risk patients
for EVAR and OAR. Although the authors conclude that
EVAR and OAR can both be safely offered to home O2-
dependent COPD patients, the limited sample size makes
a type II error quite likely.
Our study successfully documents the effect of O2-
dependent COPD in a larger number of patients than
previously reported undergoing EVAR and OAR. In look-
ing at our overall cohort of 3455 patients, O2-dependence
was associated with increased in-hospital death, pulmonary
complications, MAEs, diminished early extubation, and
decreased 5-year survival. These ﬁndings were similar in
direction but larger in magnitude for OAR than for EVAR.
As noted, O2-dependence was associated with dimin-
ished 5-year overall survival. In addition, a small but statis-
tically signiﬁcant difference was noted between OAR (78%)
and EVAR (72%), possibly reﬂecting that EVAR is offered
more readily to frail O2-dependent patients or to those
with more comorbidities who would have otherwise been
Table II. Multivariate (Cox proportional hazards)
analysis for 5-year survival
Variable HR (95% CI) P
O2-dependent COPD 3.02 (2.2-4.1) <.001
Age >80 years 2.69 (2.2-3.4) <.001
Renal insufﬁciency 1.91 (1.5-2.5) <.001
Coronary artery disease 1.46 (1.2-1.7) <.001
Congestive heart failure 1.46 (1.1-1.9) .002
Medical COPD 1.22 (1-1.5) .02
Aspirin 0.78 (0.7-0.9) .005
Statin 0.79 (0.7-0.9) .007
CI, Conﬁdence interval; COPD, chronic obstructive pulmonary disease;
HR, hazard ratio.
JOURNAL OF VASCULAR SURGERY
Volume 57, Number 6 Stone et al 1535denied OAR. This study further demonstrated that O2-
dependence was an independent predictor of increased
in-hospital death and decreased 5-year survival, whereas
some previous reports failed to independently associate
this risk factor with death.11,12 Accordingly, clinical deci-
sion making must reﬂect a careful stratiﬁcation of perioper-
ative risk factors as well as long-term survival rather than
a sole comparison of longitudinal mortality. Furthermore,
such analyses may prove to be increasingly challenging in
a cost-containment era or in accountable care organiza-
tions where procedure-associated costs will be potentially
more scrutinized and ﬁnite.
This study does have several intrinsic limitations. First,
we are unable to correlate our COPD clinical severity
scoring with objective pulmonary function testing. Never-
theless, we believe that O2-dependence serves as an objec-
tive measure of severe COPD. Furthermore, the medically
managed group may reﬂect a modest variation in pulmo-
nary function. As with many registry and administrative
data sets, we remain more limited in our ability to derive
certain patient-speciﬁc factors such as a speciﬁc inhaler vs
medication use. Nevertheless, we do believe this group
reﬂects an intermediate category of disease and likely
reﬂects a cohort less debilitated than those with a docu-
mented oxygen requirement.
In addition, the size of our O2-dependent cohort
remains modest at 4% (n ¼ 135). However, this sample
size still reﬂects more than a threefold increase in O2-
dependent patients compared with previous reports.
Furthermore, patients most debilitated by severe O2-
dependence were likely not offered surgery, and we cannot
further stratify the severity of O2-dependence of patients in
this series.
Finally, the end point, extubation in the operating
room, may be affected by variation in practice among
surgeons, with some preferentially opting to extubate
patients in a delayed fashion after an OAR. Despite this
potential confounder, the ﬁndings of this study still
demonstrated a reproducible signiﬁcant trend of COPD
severity on this end point, irrespective of procedure type,
although ampliﬁed in the OAR cohort, suggesting a dir-
ect affect of pulmonary dysfunction on successful early
extubation status.CONCLUSIONS
O2-dependent COPD is associated with increased
pulmonary complications, MAEs, and diminished long-
term survival among patients undergoing AAA repair.
These ﬁndings were magniﬁed in patients undergoing
OAR but were also present after EVAR, despite a percep-
tion that EVAR would potentially abrogate the incidence
of such morbidities. Furthermore, O2-dependent COPD
was an independent predictor of increased in-hospital death
and decreased long-term survival. Although previous
reports have highlighted the safety of AAA repair in
COPD patients, we believe that AAA repair in the post-
EVAR era, among patients with O2-dependence, still
warrants extremely prudent risk/beneﬁt assessment.
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